Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles

被引:663
作者
Xu, YM [1 ]
Du, YM [1 ]
机构
[1] Wuhan Univ, Dept Environm Sci, Wuhan 430072, Peoples R China
基金
中国国家自然科学基金;
关键词
chitosan; bovine serum albumin (BSA); nanoparticles;
D O I
10.1016/S0378-5173(02)00548-3
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Chitosan nanoparticles (CS NP) with various formations were produced based on ionic gelation process of tripolyphosphate (TPP) and chitosan. They were examined with diameter 20-200 nm and spherical shape using TEM. FTIR confirmed tripolyphosphoric groups of TPP linked with ammonium groups of chitosan in the nanoparticles. Factors affecting delivery properties of bovine serum albumin (BSA) as model protein have been tested, they included molecular weight (Mw) and deacetylation degree (DD) of chitosan, the concentration of chitosan and initial BSA, and the presence of polyethylene glycol (PEG) in encapsulation medium. Increasing Mws of chitosan from 10 to 210 kDa, BSA encapsulation efficiency was enhanced about two times, BSA total release in PBS (phosphate buffer saline) pH 7.4 in 8 days was reduced from 73.9 to 17.6%. Increasing DD from 75.5 to 92% promoted slightly the encapsulation efficiency and decelerated the release rate. The encapsulation efficiency was highly decreased by increase of initial BSA and chitosan concentration; higher loading capacity of BSA speeded the BSA release from the nanoparticles. Adding PEG hindered the BSA encapsulation and accelerated the release rate. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:215 / 226
页数:12
相关论文
共 26 条
[1]
Chitosan as a nasal delivery system: The effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers [J].
Aspden, TJ ;
Mason, JDT ;
Jones, NS ;
Lowe, J ;
Skaugrud, O ;
Illum, L .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (04) :509-513
[2]
Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO
[3]
2-4
[4]
CHITOSAN-ALGINATE COMPLEX COACERVATE CAPSULES - EFFECTS OF CALCIUM-CHLORIDE, PLASTICIZERS, AND POLY-ELECTROLYTES ON MECHANICAL STABILITY [J].
DALY, MM ;
KNORR, D .
BIOTECHNOLOGY PROGRESS, 1988, 4 (02) :76-81
[5]
Enhancement of nasal absorption of insulin using chitosan nanoparticles [J].
Fernández-Urrusuno, R ;
Calvo, P ;
Remuñán-López, C ;
Vila-Jato, JL ;
Alonso, MJ .
PHARMACEUTICAL RESEARCH, 1999, 16 (10) :1576-1581
[6]
FLORY PJ, 1953, PRINCIPLES POLYM CHE, P69
[7]
OPTIMIZATION OF MICROENCAPSULATION PARAMETERS - SEMIPERMEABLE MICROCAPSULES AS A BIOARTIFICIAL PANCREAS [J].
GOOSEN, MFA ;
OSHEA, GM ;
GHARAPETIAN, HM ;
CHOU, S ;
SUN, AM .
BIOTECHNOLOGY AND BIOENGINEERING, 1985, 27 (02) :146-150
[8]
Illum L, 1998, PHARM RES-DORDR, V15, P1326
[9]
Chitosan nanoparticles as delivery systems for doxorubicin [J].
Janes, KA ;
Fresneau, MP ;
Marazuela, A ;
Fabra, A ;
Alonso, MJ .
JOURNAL OF CONTROLLED RELEASE, 2001, 73 (2-3) :255-267
[10]
Polysaccharide colloidal particles as delivery systems for macromolecules [J].
Janes, KA ;
Calvo, P ;
Alonso, MJ .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (01) :83-97